United States · FDA National Drug Code directory
Gomekli
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 82448-134_5132f76b-c3da-4831-833c-c48cb8eee26a
- Product NDC
- 82448-134
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- mirdametinib
- Labeler
- SpringWorks Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250211
- Source listing expiry
- 20271231
Source-listed ingredients
- MIRDAMETINIB — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 42 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-42) · 82448-134-42
- 84 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-84) · 82448-134-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →